US PATENT SUBCLASS 514 / 922
SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT
Current as of:
June, 1999
Click
HD
for Main Headings
Click for
All Classes
Internet Version by
PATENTEC
© 1999
Terms of Use
514 /
HD
DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS
922
SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT
DEFINITION
Classification: 514/922
SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED
INGREDIENT:
Subject matter involving the reducing or eliminating of an undesirable side effect of a given drug by concurrent administration of a second designated compound.
